France Anticoagulant Rodenticides Market Size & Outlook

The anticoagulant rodenticides market in France is expected to reach a projected revenue of US$ 63.0 million by 2030. A compound annual growth rate of 2.9% is expected of France anticoagulant rodenticides market from 2022 to 2030.

Revenue, 2021 (US$M)
$48.9
Forecast, 2030 (US$M)
$63.0
CAGR, 2022 - 2030
2.9%
Report Coverage
France

France anticoagulant rodenticides market highlights

  • The France anticoagulant rodenticides market generated a revenue of USD 48.9 million in 2021 and is expected to reach USD 63.0 million by 2030.
  • The France market is expected to grow at a CAGR of 2.9% from 2022 to 2030.
  • In terms of segment, 2nd gen was the largest revenue generating product in 2021.
  • 1st Gen is the most lucrative product segment registering the fastest growth during the forecast period.


Anticoagulant rodenticides market data book summary

Market revenue in 2021USD 48.9 million
Market revenue in 2030USD 63.0 million
Growth rate2.9% (CAGR from 2021 to 2030)
Largest segment2nd gen
Fastest growing segment1st Gen
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentation1st Gen, 2nd Gen
Key market players worldwideNeogen Corp, Basf SE, Rentokil Initial PLC, Bayer AG, Syngenta, PelGar International, Liphatech


Other key industry trends

  • In terms of revenue, France accounted for 7.2% of the global anticoagulant rodenticides market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, France anticoagulant rodenticides market is projected to lead the regional market in terms of revenue in 2030.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 25.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Anticoagulant Rodenticides Market Companies

Name Profile # Employees HQ Website

France anticoagulant rodenticides market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulant rodenticides market will help companies and investors design strategic landscapes.


2nd gen was the largest segment with a revenue share of 59.71% in 2021. Horizon Databook has segmented the France anticoagulant rodenticides market based on 1st gen, 2nd gen covering the revenue growth of each sub-segment from 2018 to 2030.


In Paris, diseased rodents have become a major issue, which was also blamed for plague in the 14th century that devastated human population of the city. It is estimated that there are more than 3 to 4 million rats in Paris and the population is increasing exponentially. Such factors may drive the demand for effective anticoagulant rodenticides over the coming years.


Opening of riverside infrastructure, rising levels of Seine River, and the European Union’s restriction on the use of pesticide products are some of the major reasons behind increasing rodent population. Active ingredients such as bromadiolone, warfarin, brodifacoum, diphacinone, and others can be used to manage such populations of rodents. This, in turn, will propel the demand for anticoagulant rodenticides over the coming years.

Reasons to subscribe to France anticoagulant rodenticides market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France anticoagulant rodenticides market databook

  • Our clientele includes a mix of anticoagulant rodenticides market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France anticoagulant rodenticides market , including forecasts for subscribers. This country databook contains high-level insights into France anticoagulant rodenticides market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France anticoagulant rodenticides market size, by product, 2018-2030 (US$M)

France Anticoagulant Rodenticides Market Outlook Share, 2021 & 2030 (US$M)

France anticoagulant rodenticides market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more